Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, March 2011

Sort by: Newest first Oldest first A-Z Z-A

  • Computer artwork of monoclonal antibodies

    “Kwik-Fiximab” — how a monoclonal antibody transformed care of Crohn’s Subscription

    25 MAR 2011 7:09

    In this article on landmark drugs, Jenny Bryan takes a look at how monoclonal antibodies transformed the lives of millions of people with autoimmune disorders 

  • PJ letters (26 March 2011) (RPS members only) Subscription

    25 MAR 2011 7:04

    The letters below have been published in the 26 March 2011 issue of The Pharmaceutical Journal.The letters pages are available as a downloadable PDF (880k)

  • “Yes/No” voting options

    RPS ballot on pharmaceutical scientist membership set for June

    24 MAR 2011 15:54

    Voting on whether pharmaceutical scientists will be invited to join the Royal Pharmaceutical Society is to go ahead in June 2011, the RPS Assembly decided at its meeting in Cardiff this week (23 March 2011).

  • Medicines and calculator

    Value-based pricing must account for supply costs

    24 MAR 2011 13:35

    Pricing arrangements for branded medicines should take account of supply chain costs and incentivise the efficient supply of medicines to pharmacies, the Pharmaceutical Services Negotiating Committee has said.

  • old man on oxygen

    Tiotropium more effective at reducing COPD exacerbations than salmeterol

    24 MAR 2011 13:15

    Tiotropium is more effective than salmeterol in preventing exacerbations in patients with moderate-to-very-severe chronic obstructive pulmonary disease, according to research published in The New England Journal of Medicine (2011;364:1093).

  • Riastap vial

    Human fibrinogen Riastap launched

    24 MAR 2011 13:08

    Patients with coagulation problems caused by fibrinogen deficiency are now able to benefit from a human fibrinogen product.The CSL Behring product, marketed under the brand name Riastap, was launched earlier this year.Riastap is indicated for the treatment of bleeding in patients with congenital hypo- and afibrinogenaemia with bleeding tendency.

  • Pioglitazone could halt pre-diabetes conversion

    24 MAR 2011 12:52

    Pioglitazone treatment reduces the risk of patients with pre-diabetes developing diabetes by 72 per cent, according to research published in The New England Journal of Medicine (2011;364:1104).

  • old lady

    NICE extends Alzheimer’s guidance

    24 MAR 2011 12:05

    Recommendations on the use of three acetylcholinesterase inhibitors have been extended to include mild Alzheimer’s disease in updated guidance issued by the National Institute for Health and Clinical Excellence this week.

  • EU clinical trials register goes live

    24 MAR 2011 11:36

    The EU clinical trials register — — was launched this week by the European Medicines Agency.The register allows public access to information on interventional clinical trials for medicines authorised in the 27 EU member states and Iceland, Liechtenstein and Norway.

  • Azacitidine approved by NICE

    24 MAR 2011 11:30

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.